Introduction
Diffuse neonatal hemangiomatosis (DNH) is a rare condition with a very high mortality rate (50-90%) if left untreated [1] . Hemangiomas otherwise are the most common vascular tumours of infancy with excellent prognosis. However, the presence of multiple hemangiomas is associated with a strong possibility of visceral organ involvement, which is termed diffuse neonatal hemangiomatosis [2] . Visceral lesions are most commonly found in the liver followed by nervous system, intestine, lungs, rarely skeletal system and proliferate till infancy. The common causes of mortality are high-output cardiac failure as a result of arteriovenous shunting in liver or haemorrhage in intestine or brain [3] . Prompt treatment with corticosteroids or beta blockers like propranolol inhibits the proliferation, promotes early regression of hemangiomas and is life saving [4] .
Case Report
A 20-day-old, full term male baby with birth weight of 2.5 kg was referred to the out-born nursery of our tertiary care hospital with a history of insidious onset respiratory distress, difficulty in feeding since day 5 of life and multiple cutaneous hemangiomas since birth. The baby was delivered by caesarean section at a private hospital with an uneventful antenatal Diffuse neonatal hemangiomatosis presenting as congestive heart failure Sheetal Agarwal 1 , Anu Sharma 1 , Arti Maria
Diffuse neonatal hemangiomatosis is a rare condition with a very high mortality rate if left untreated. We report a neonate having around 490 cutaneous and multiple diffuse liver hemangiomas presenting as congestive heart failure. Prompt treatment was instituted with decongestive drugs and prednisolone for anticipated life threatening complications due to hepatic hemangiomas. Propranolol was added later as it is known to precipitate congestive failure and also to avoid long-term complications of steroids. The child responded well. However, there is no consensus regarding the initial line of management, which needs to be individualized keeping in mind the efficacy, long-term side effects of the drug and the clinical presentation. taper steroids in four weeks to avoid long-term complications of steroids. However, they had to be tapered at three weeks due to intercurrent systemic bacterial infection.
ABSTRACT
After eight weeks, an ultrasound of the abdomen demon- [6] . Hence, these hemangiomas tend to increase initially for 8-12 months (proliferative phase), followed by regression over the next 1-5 years (involuting phase), with continuous improvement until 6-12 years (involuted phase). An early diagnosis and prompt treatment inhibits the progression and induces regression of the vascular lesions, thus reducing the mortality to 27% [7] .
Although a variety of medical and surgical treatment options are available, drug therapy is the primary mode of treatment, and most cases of infantile hemangiomas with visceral involvement have been successfully treated by corticosteroids as the first-line agents [8, 9] . However, keeping in mind their adverse effects in the long run, we reviewed the literature for other medical options. Propranolol, due its vasoconstrictor and inhibitory effects on endothelial and fibroblast growth factor, has shown promising results in early induction of cell apoptosis, involution of hemangiomas and arteriovenous formations (AVMs) [8, 14] . Previously, it was
